Aster DM Healthcare Ltd

Aster DM Health. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Aster DM Healthcare Ltd

₹ 416 1.08%
27 Sep - close price
asterdmhealthcare.com BSE: 540975 NSE: ASTERDM
About

Aster DM Healthcare Limited is one of the largest integrated private healthcare service providers operating in GCC (Gulf Cooperation Council) countries and an emerging player in India. With an inherent emphasis on clinical excellence, it is one of the few entities in the world with a strong presence across primary, secondary, tertiary and quaternary healthcare. [1]

Key Points

Business Segments Q1 FY25
1) Hospitals and Clinics (94%): The company has a network of 19 hospitals (vs 14 hospitals in FY22) and 13 clinics. These hospitals are located in the Maharastra (1), Karnataka (4), Kerala (6), Andhra (6) & Telangana (1). [1]

This business has registered a 23% YoY revenue growth and EBITDA grew by 28% in FY24, on the backdrop of an increased bed capacity of 550 beds, and cost optimization measures. Material cost has declined from 25% in FY22 to 22% in FY24. [2] [3]

Website BSE NSE
  • Market Cap ₹ 20,757 Cr.
  • Current Price ₹ 416
  • High / Low ₹ 558 / 309
  • Stock P/E 3.62
  • Book Value ₹ 58.4
  • Dividend Yield 0.48 %
  • ROCE 7.37 %
  • ROE 5.55 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 27.5% CAGR over last 5 years
  • Company's median sales growth is 37.4% of last 10 years

Cons

  • Stock is trading at 7.11 times its book value
  • Company has a low return on equity of 5.12% over last 3 years.
  • Promoters have pledged 98.9% of their holding.
  • Earnings include an other income of Rs.6,030 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024
252 279 295 291 328 378 399 429 457 509 524 546 566
232 241 246 247 272 301 328 344 374 423 433 446 464
Operating Profit 20 37 49 44 56 77 71 85 83 86 92 100 101
OPM % 8% 13% 17% 15% 17% 20% 18% 20% 18% 17% 17% 18% 18%
7 13 7 55 9 18 11 12 11 20 13 4 5,992
Interest 10 10 12 11 11 12 14 15 16 21 21 21 21
Depreciation 25 25 25 24 24 25 26 29 26 29 31 36 35
Profit before tax -7 15 19 63 30 57 41 54 53 57 53 47 6,037
Tax % 0% 0% 0% -0% 0% 0% 17% 4% 0% -4% 0% 117% 0%
-7 15 19 63 30 57 35 52 53 59 53 -8 6,008
EPS in Rs -0.15 0.31 0.39 1.26 0.60 1.14 0.69 1.04 1.06 1.18 1.06 -0.16 120.28
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
1 1 53 189 380 530 595 760 747 1,116 1,534 2,036 2,145
8 12 114 227 427 519 554 686 704 963 1,240 1,671 1,766
Operating Profit -7 -11 -60 -38 -47 12 41 74 42 153 293 366 378
OPM % -762% -1,256% -114% -20% -12% 2% 7% 10% 6% 14% 19% 18% 18%
10 86 40 51 390 14 83 113 21 82 50 48 6,030
Interest 0 3 34 135 228 54 11 33 36 47 56 83 84
Depreciation 1 1 22 48 68 59 64 89 95 99 104 121 130
Profit before tax 2 72 -77 -170 47 -87 49 65 -68 90 182 209 6,194
Tax % 0% 2% 1% 0% 0% 0% 1% 6% 1% -0% 5% 25%
2 70 -78 -170 47 -87 48 61 -69 90 173 157 6,112
EPS in Rs 0.15 1.86 -2.00 -4.21 1.16 -1.73 0.95 1.21 -1.38 1.81 3.47 3.14 122.36
Dividend Payout % 0% 89% 0% 0% 0% 0% 0% 0% 0% 0% 0% 64%
Compounded Sales Growth
10 Years: 117%
5 Years: 28%
3 Years: 40%
TTM: 29%
Compounded Profit Growth
10 Years: 8%
5 Years: 28%
3 Years: 63%
TTM: 2826%
Stock Price CAGR
10 Years: %
5 Years: 29%
3 Years: 26%
1 Year: 27%
Return on Equity
10 Years: -1%
5 Years: 3%
3 Years: 5%
Last Year: 6%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 125 375 389 403 403 505 505 497 497 500 500 500
Reserves 343 103 209 535 1,925 2,421 2,475 2,434 2,367 2,081 2,257 2,420
22 266 384 1,914 645 110 125 349 417 895 1,072 1,216
9 24 124 168 251 257 271 273 307 286 274 402
Total Liabilities 499 768 1,105 3,021 3,224 3,293 3,376 3,552 3,589 3,762 4,102 4,538
36 37 469 547 714 772 753 1,016 1,009 1,013 1,008 1,333
CWIP 123 287 100 130 63 17 70 20 11 23 67 39
Investments 227 266 317 2,037 2,137 2,086 2,095 2,150 2,151 2,166 2,141 2,176
114 178 219 307 309 417 458 366 418 560 886 990
Total Assets 499 768 1,105 3,021 3,224 3,293 3,376 3,552 3,589 3,762 4,102 4,538

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
-51 -3 -51 98 42 78 246 413
-251 -18 -36 40 -38 -49 -332 -342
222 95 7 -126 -12 -18 92 -67
Net Cash Flow -80 74 -80 12 -9 11 6 3

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 365 742 41 28 24 21 22 21 21 20 26 23
Inventory Days 171 100 66 42 38 49 38 32 38 39
Days Payable 288 150 102 57 64 240 270 173 228 200
Cash Conversion Cycle 365 742 -75 -22 -13 6 -4 -170 -210 -122 -163 -139
Working Capital Days 1,604 4,109 -59 -48 77 29 86 -45 -40 -22 8 -6
ROCE % 0% 12% -5% -4% -4% -1% 2% 3% -1% 4% 7% 7%

Shareholding Pattern

Numbers in percentages

1 Recently
Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
37.88% 37.88% 37.88% 37.88% 37.88% 37.88% 41.88% 41.88% 41.88% 41.88% 41.88% 41.88%
10.80% 10.95% 11.03% 11.44% 11.77% 42.49% 38.63% 38.82% 40.22% 41.00% 33.48% 27.08%
8.48% 8.45% 8.64% 9.66% 8.99% 8.93% 8.93% 8.62% 7.64% 7.15% 13.70% 16.35%
42.36% 42.24% 41.99% 40.57% 40.91% 10.25% 10.12% 10.26% 9.85% 9.61% 10.59% 14.38%
0.48% 0.47% 0.46% 0.45% 0.45% 0.44% 0.43% 0.42% 0.41% 0.37% 0.35% 0.32%
No. of Shareholders 87,80480,74680,42778,37480,91384,57382,12971,37967,67367,33180,9312,06,660

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls